Targeted and shallow whole genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers.
Jamieson A, Sobral de Barros J, Cochrane DR, Douglas JM, Shankar S, Lynch BJ, Leung S, Martin S, Senz J, Lum A, Drew Y, Gilks CB, Huntsman DG, McAlpine JN.
Jamieson A, et al. Among authors: douglas jm.
Clin Cancer Res. 2024 Mar 27. doi: 10.1158/1078-0432.CCR-23-3689. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38536067